OIG Increases Expectations for Compliance Officers in Its New Compliance Program Guidance – What Compliance Officers at Pharmaceutical and Medical Device Companies Need to Consider | King & Spalding
On November 6, 2023, the U.S. Department of Health and Human Services Office of Inspector General (“OIG”) issued its anticipated General Compliance Program Guidance (“GCPG”) for the...
Source: jdsupra.com